期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Immune checkpoint therapy for pancreatic cancer 被引量:5
1
作者 Henrik Johansson Roland Andersson +3 位作者 Monika Bauden sarah hammes Stefan Holdenrieder Daniel Ansari 《World Journal of Gastroenterology》 SCIE CAS 2016年第43期9457-9476,共20页
Novel treatment modalities are necessary for pancreatic cancer. Immunotherapy with immune checkpoint inhibition has shown effect in other solid tumors, and could have a place in pancreatic cancer treatment. Most avail... Novel treatment modalities are necessary for pancreatic cancer. Immunotherapy with immune checkpoint inhibition has shown effect in other solid tumors, and could have a place in pancreatic cancer treatment. Most available clinical studies on immune checkpoint inhibitors for pancreatic cancer are not yet completed and are still recruiting patients. Among the completed trials, there have been findings of a preliminary nature such as delayed disease progression and enhanced overall survival after treatment with immune checkpoint inhibitors in mono- or combination therapy. However, due to small sample sizes, major results are not yet identifiable. The present article provides a clinical overview of immune checkpoint inhibition in pancreatic cancer. Pub Med, Clinical Trials.gov and American Society of Clinical Oncology's meeting abstracts were systematically searched for relevant clinical studies. Four articles, five abstracts and 25 clinical trials were identified and analyzed in detail. 展开更多
关键词 Pancreatic cancer Immune checkpoint inhibitors Clinical trials
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部